InsidersTradesSigma
Follow the Nu-Med Plus, Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €1.5m. The latest transaction was filed on 25 August 2026 (J). Among the most active insiders: TEJADA FRED. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Nu-Med Plus, Inc. es una empresa que cotiza en el mercado XNAS. Se especializa en el desarrollo de soluciones médicas innovadoras.